Combined therapy of EGFR TKI and VEGFR TKI may produce a greater therapeutic benefit and overcome EGFR TKI-induced resistance. However, a previous study shows that a combination of EGFR TKI erlotinib ...
Certara, the global model-informed drug development and decision support leader, announced the launch of Phoenix 8.2, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) modelling ...
Bioavailability of the hedgehog pathway inhibitor GDC-0449 in a phase I pharmacokinetic (PK) study in healthy female subjects. Background: Serdemetan is a compound that can cause replicative stress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback